CD8A and glioblastoma: Here, we demonstrate that the ability to suppress the percentage of TIM-3 positivity following the activation of CD4+ and CD8+ T cells, as well as NK cells, from glioblastoma patients is significantly reduced, and that these cells display reduced BAT3, CD69, and IFNγ expression compared to healthy donors.